CLO21-022: Efficacy and Safety Outcomes With Therapies for Stage I-III Merkel Cell Carcinoma (MCC): A Systematic Literature Review

View More View Less
  • 1 Massachusetts General Hospital, Boston, MA
  • 2 Merck KGaA, Darmstadt, Germany
  • 3 EMD Serono, Inc., Rockland, MA; an affiliate of Merck KGaA, Darmstadt, Germany
  • 4 OPEN VIE (an OPEN Health Company), London, United Kingdom
Restricted access

Corresponding Author: Murtuza Bharmal, PhD
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 110 110 45
PDF Downloads 145 145 57
EPUB Downloads 0 0 0